Lotus Pharm vs Pharmosa Biopharm: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Pharmosa Biopharm (6875) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Pharmosa Biopharm

0%+226%-100%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYPharmosa BiopharmYoY
Oct 2026NT$2.13 billion-22.5%NT$1.6 million—
Sep 2026NT$2.77 billion+128.0%NT$4.6 million—
Aug 2026NT$2.11 billion+81.7%NT$3,000—
Jul 2026NT$2.49 billion+3.9%NT$248,000-93.8%
Jun 2026NT$3.4 billion+225.5%NT$0—
May 2026NT$2.32 billion+105.8%NT$0-100.0%
Apr 2026NT$3.09 billion+19.9%NT$0—
Mar 2026NT$4.35 billion+173.6%NT$1.8 million—
Feb 2026NT$2.24 billion+131.5%NT$0—
Jan 2026NT$2.05 billion-5.5%NT$0—
Dec 2025NT$2.44 billion+66.9%NT$2 million-54.4%
Nov 2025NT$1.06 billion-0.2%NT$45.6 million—
Oct 2025NT$2.75 billion+46.0%NT$0-100.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16